Cargando…

A Stability Indicating HPLC Assay Method for Analysis of Rivastigmine Hydrogen Tartrate in Dual-Ligand Nanoparticle Formulation Matrices and Cell Transport Medium

The objective of this study was to develop and validate a method for quantitative analysis of rivastigmine hydrogen tartrate (RHT) in dual-ligand polymeric nanoparticle formulation matrices, drug release medium, and cellular transport medium. An isocratic HPLC analysis method using a reverse phase C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huda, Naz Hasan, Gauri, Bhawna, Benson, Heather A. E., Chen, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852878/ https://www.ncbi.nlm.nih.gov/pubmed/29686925 http://dx.doi.org/10.1155/2018/1841937

Ejemplares similares

MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
por: Shamsi, Anas, et al.
Publicado: (2020)

QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
por: Arora, Deepshi, et al.
Publicado: (2022)

Morpholin-4-ium hydrogen tartrate
por: Liu, Ming-Liang
Publicado: (2012)

Multispectroscopic and Molecular Docking Insight into Elucidating the Interaction of Irisin with Rivastigmine Tartrate: A Combinational Therapy Approach to Fight Alzheimer’s Disease
por: Waseem, Rashid, et al.
Publicado: (2021)

Comparative study of rivastigmine and galantamine on the transgenic Drosophila model of Alzheimer's disease
por: Siddique, Yasir Hasan, et al.
Publicado: (2022)

Development and Validation of a Spectrofluorimetric Method for the Estimation of Rivastigmine in Formulations
por: Kapil, R., et al.
Publicado: (2009)

Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases
por: Shamsi, Anas, et al.
Publicado: (2019)

Spectrophotometric methods for determination of zolpidem tartrate in tablet formulation
por: Chomwal, Rajiv, et al.
Publicado: (2010)

Analytical Method for the Simultaneous Estimation of Hydrochlorothiazide and Metoprolol Tartrate using RP HPLC
por: Rawool, N. D., et al.
Publicado: (2011)

Morpholin-4-ium hydrogen l-tartrate monohydrate
por: Kumar, T. Kishore, et al.
Publicado: (2012)

Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices
por: Pinho, A.R., et al.
Publicado: (2019)

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s disease
por: Ismail, Manal Fouad, et al.
Publicado: (2013)

Esophagectasis Related to Rivastigmine
por: Sasaki, Osamu, et al.
Publicado: (2019)

Stress Degradation Studies on Varenicline Tartrate and Development of a Validated Stability-Indicating HPLC Method
por: Pujeri, Sudhakar S., et al.
Publicado: (2012)

Formulation and evaluation of new long acting metoprolol tartrate ophthalmic gels
por: Abou el Ela, Amal El Sayeh F., et al.
Publicado: (2014)

Rivastigmine-Loaded L-Lactide-Depsipeptide Polymeric Nanoparticles: Decisive Formulation Variable Optimization
por: Pagar, Kunal, et al.
Publicado: (2013)

Flupentixol tartrate
por: Yamuna, Thammarse S., et al.
Publicado: (2014)

Formulation and Evaluation of Controlled-Release Tablet of Zolpidem Tartrate by Melt Granulation Technique
por: Prajapati, Shailesh T., et al.
Publicado: (2011)

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems
por: Sun, Jianguo, et al.
Publicado: (2017)

1,10-Phenanthrolin-1-ium hydrogen d,l-tartrate dihydrate
por: Cheng, Sit Foon, et al.
Publicado: (2011)

1,10-Phenanthrolin-1-ium hydrogen (S,S)-tartrate trihydrate and a correction
por: Derikvand, Zohreh, et al.
Publicado: (2009)

Obstructive nephropathy induced with DL-potassium hydrogen tartrate in F344 rats
por: Inoue, Kaoru, et al.
Publicado: (2015)

Preparation, characterization, and in vivo evaluation of a polymorphic form of valnemulin hydrogen tartrate
por: Zhu, Xinle, et al.
Publicado: (2019)

Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
por: Dubey, Akhilesh, et al.
Publicado: (2014)

Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine
por: Salatin, Sara, et al.
Publicado: (2020)

Rivastigmine in the treatment of Alzheimer’s disease: an update
por: Onor, Maria Luisa, et al.
Publicado: (2007)

Rivastigmine in the treatment of patients with Alzheimer’s disease
por: Müller, Thomas
Publicado: (2007)

Acquired Localized Hypertrichosis Induced by Rivastigmine
por: Imbernón-Moya, Adrian, et al.
Publicado: (2016)

Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease
por: Shimura, Hideki, et al.
Publicado: (2021)

ZolpiMist™: a new formulation of zolpidem tartrate for the short-term treatment of insomnia in the US
por: Neubauer, David N
Publicado: (2010)

Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease
por: Rompicherla, Sampath Kumar L., et al.
Publicado: (2021)

Re‐evaluation of l(+)‐tartaric acid (E 334), sodium tartrates (E 335), potassium tartrates (E 336), potassium sodium tartrate (E 337) and calcium tartrate (E 354) as food additives
por: Younes, Maged, et al.
Publicado: (2020)

An Atypical Cutaneous Reaction to Rivastigmine Transdermal Patch
por: Grieco, T., et al.
Publicado: (2011)

Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Reingold, Jennifer L, et al.
Publicado: (2007)

Rivastigmine in Chinese patients with subcortical vascular dementia
por: Mok, Vincent, et al.
Publicado: (2007)

Effects of rivastigmin tartarat in the therapy of patients with schizophrenia
por: Djordjevic, Snezana, et al.
Publicado: (2010)

Direct Asymmetric Reductive Amination for the Synthesis of (S)-Rivastigmine
por: Gao, Guorui, et al.
Publicado: (2018)

Treatment of pediatric antimuscarinic delirium with oral rivastigmine
por: Yakey, Brandtly, et al.
Publicado: (2023)

Bis(melaminium) tartrate dihydrate
por: Su, Hong, et al.
Publicado: (2009)

The Treatment of Rhinosporidium by Antimony Tartrate
por: Wright, Robert E.
Publicado: (1923)

Cannot write session to /tmp/vufind_sessions/sess_j4uim4p4an9u31gtt44atmt4bc